Cetya Therapeutics
The coordinates that you can use in navigation applications to get to find Cetya Therapeutics quickly are 40.5229438 ,-105.1313308
Contact and Address
| Address: | 4605 Valley Ridge Ct, Fort Collins, CO 80526, USA |
|---|---|
| Postal code: | 80526 |
| Phone: | (303) 895-8216 |
| Website: | https://cetya-therapeutics.com/ |
Location & routing
Reviews
-
Brandon Hiatt
(May 24, 2021, 4:22 pm)Quick and polite service. Longest I've ever had to wait was 4 minutes. They'll get you in and out as fast as they can!
-
Nathan Carter
(April 14, 2021, 4:17 pm)As an employee of the Reynolds rd McDonald's I can say that hands down my shift is dedicated to delivering the best services possible and are happy to assist you in any way possible to insure only the best experience possible
Photos of Cetya Therapeutics
Cetya Therapeutics On the Web
Home - Cetya Therapeutics
Cetya Therapeutics, Inc. is a Delaware C-Corporation formed in 2012 to develop histone deacetylase inhibitors (HDACi) based on analogs of largazole. Some of these analogs incorporate receptor ligands, which enable them to target specific cell types or tumors. This targeting approach is unique for HDACi...
Leadership - Cetya Therapeutics
(970) 818-8343. info@cetya-therapeutics.com. He has served as an advisor to Cetya since August, 2013, and as its CEO and a member of its Board of Directors since July, 2014...
Contact - Cetya Therapeutics
info@cetya-therapeutics.com. Company. Leadership. info@cetya-therapeutics.com. Send us a message.
Cetya Therapeutics - CB Insights
Cetya Therapeutics develops drugs targeting epigenetic mechanisms for unmet medical needs. Cetya works on technology for a series of class I isoform-specific histone deacetylase inhibitors that hold significant promise to overcome the clinical limita...Show all. Phone: 303-895-8216.
Pharmaceuticals Companies in Fort Collins, Colorado - Manta
Cetya Therapeutics. 4605 Valley Ridge Court Fort Collins, CO 80526. 4605 Valley Ridge Court Fort Collins, CO 80526. (303) 895-8216. View Contact Info. pharmaceutical company, cancer research, fort collins, co.
PDF Cetya Therapeutics
Cetya Therapeutics. One-Sentence Summary of What You Do: Cetya is developing HDAC inhibitors which are analogs of largazole, a natural product Class I-restricted HDAC inhibitor.
Cetya Therapeutics Company Profile: Valuation & Investors | PitchBook
To explore Cetya Therapeutics's full profile, request a free trial. Cetya Therapeutics Valuation and Funding. Deal Type. Date. Cetya Therapeutics. Chief Executive Officer & Board Member. 000 0000. David Stevens. Cetya Therapeutics. Board Member.
PDF Cetya Therapeutics, Inc.
CETYA Therapeutics was founded in July of 2012 to commercialize analogs of the class I isoform selective histone deacetylase inhibitor (HDACi) CETYA Therapeutics isoform selective HDACi's target genes that have been turned off due to biochemical modification of the proteins that package...
Cetya Therapeutics | Crunchbase
Cetya Therapeutics is a pioneering leader in histone deacetylase inhibitor research, focusing on largazole analogs. Cetya has developed a portfolio of over 30 largazole analogs to evaluate in various therapeutic indications. The largazole scaffold also can be further modified to develop...
CETYA Therapeutics, Inc. | LinkedIn
CETYA Therapeutics develops drugs targeting epigenetic mechanisms for unmet medical needs. Our lead technology is a best-in-class series of class I isoform specific histone deacetylase inhibitors that hold significant promise to overcome the clinical limitations of first generation HDACi's.